DPP4 and pancreatitis: Numerous challenges in development of DPP-4 inhibitors have been seen such as % yield of synthesized compounds, gastrointestinal problems, skin reactions and majorly high risk of developing pancreatitis have been observed experiencing severe pain in upper abdomen.